Drug Channels
JANUARY 27, 2023
Saket discusses market access and contracting strategies for medical benefit products when pharmacy benefit biosimilar therapies launch. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. He then describes how to automate formulary and medical policies to protect manufacturers from overpayment.
Drug Channels
OCTOBER 17, 2022
Copyright © 2006-2022 Pembroke Consulting, Inc. Don’t miss the chance to unite with colleagues and master the complexities of pharmacy and distribution models to accelerate patient access! The content of Sponsored Posts does not necessarily reflect the views of Pembroke Consulting, Inc., Drug Channels, or any of its employees.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Pharma Data
APRIL 4, 2023
Biosimilars help patients to gain broader access to effective and high-quality treatments that improve their disease therapies,” said Rebecca Guntern, Head of Region Europe, Sandoz. It has a leading global portfolio with eight marketed biosimilars and a further 15+ in various stages of development.
Drug Channels
JUNE 26, 2023
Copyright © 2006-2023 Pembroke Consulting, Inc. View the agenda for Health Systems & Pharma Partnering 2023 to see the complete picture – the program, speakers, and more, and visit www.informaconnect.com/health-systems-partnering for further details and to register. Drug Channels, or any of its employees. d/b/a Drug Channels Institute.
Drug Channels
JULY 11, 2022
Director, Cell Therapy Operations and Patient Services, Gamida Cell Austin Fisher, Executive Director, CART Patient Support and Distribution, Autolus Chris Boneham, Vice President Market Access U.S., Copyright © 2006-2022 Pembroke Consulting, Inc. Drug Channels, or any of its employees. d/b/a Drug Channels Institute.
Drug Channels
NOVEMBER 24, 2020
My recent tweets have highlighted: doctors against step therapy, distribution of COVID-19 therapies, biosimilar savings, copay accumulator data, prospects for smaller PBMs, the new transparency rule, specialty pharmacy profit metrics, the future of oncology practices, and an update on Diplomat founder Phil Hagerman. to 1:15 p.m.
Drug Channels
JUNE 5, 2023
Copyright © 2006-2023 Pembroke Consulting, Inc. These posts do not necessarily reflect our opinions and should not be considered endorsements. To find out how you can publish a guest post on Drug Channels, please contact Paula Fein (paula@DrugChannels.net). d/b/a Drug Channels Institute. This Feed is for personal non-commercial use only.
Expert insights. Personalized for you.
97 
Let's personalize your content